- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens resumes oncology shipments
The Oncology Care Systems division of Siemens Medical Systemshas received Food and Drug Administration clearance to resumeshipping and manufacturing in the U.S., the vendor reported lastweek. Siemens halted domestic shipments from the Concord,
The Oncology Care Systems division of Siemens Medical Systemshas received Food and Drug Administration clearance to resumeshipping and manufacturing in the U.S., the vendor reported lastweek. Siemens halted domestic shipments from the Concord, CA,facility last year after FDA audits uncovered problems in manufacturingprocesses at the plant (SCAN 10/12/94).
Siemens received FDA approval on Nov. 2 to resume U.S. shipping,and got the agency's go-ahead in October to manufacture for U.S.customers. The facility has been shipping and manufacturing forinternational customers since March, the company reported. Theplant makes radiation oncology treatment and verification products.
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).
